POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)
Conditions:   Mycobacterium Tuberculosis, Protection Against;   Tuberculosis Interventions:   Biological: ChadOx1 85A - aerosol;   Biological: ChadOx1 85A - IM Sponsors:   François Spertini;   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

POC Strategies to Improve TB Care in Advanced HIV Disease
Conditions:   Extrapulmonary Tuberculosis;   Tuberculosis, Pulmonary;   Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome Intervention:   Diagnostic Test: LF-LAM Sponsors:   University of Southern Denmark;   Odense University Hospital;   National Tuberculosis Control Programme, Ghana;   Odense Patient Data Explorative Network;   University of Ghana;   Tema General Hospital, Ghana;   Lekma Hospital, ...
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials

Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Drug: Dose escalation Sponsors:   University of Liverpool;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Joint Clinical Research Centre, Kampala, Uganda;   University of Cape Town, Cape Town, South Africa;   Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda;   University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions:   Tuberculosis;   HIV Intervention:   Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Drug: Dose escalation Sponsors:   University of Liverpool;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Joint Clinical Research Centre, Kampala, Uganda;   University of Cape Town, Cape Town, South Africa;   Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda;   University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions:   Tuberculosis;   HIV Intervention:   Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Drug: Dose escalation Sponsors:   University of Liverpool;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Joint Clinical Research Centre, Kampala, Uganda;   University of Cape Town, Cape Town, South Africa;   Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda;   University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions:   Tuberculosis;   HIV Intervention:   Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Drug: Dose escalation Sponsors:   University of Liverpool;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Joint Clinical Research Centre, Kampala, Uganda;   University of Cape Town, Cape Town, South Africa;   Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda;   University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children
Conditions:   Tuberculosis;   HIV Intervention:   Other: External validation of the PAANTHER TB treatment decision algorithm Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Drug: Dose escalation Sponsors:   University of Liverpool;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Joint Clinical Research Centre, Kampala, Uganda;   University of Cape Town, Cape Town, South Africa;   Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda;   University of Turin, Turin, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes
Conditions:   Tuberculosis;   Adherence, Patient;   Adherence, Medication;   Drug-resistant Tuberculosis Interventions:   Behavioral: Keheala Mobile Health Platform and Behavioral Interventions;   Behavioral: Social and Behavior Change Communication (SBCC);   Behavioral: SMS Reminder;   Other: Standard of Care Sponsors:   Massachusetts Institute of Technology;   Keheala;   United States Agency for International Development (USAID);   Kenya National Tuberculosis, Leprosy and Lung Disease Program;   McGill&...
Source: ClinicalTrials.gov - October 8, 2019 Category: Research Source Type: clinical trials

Screening for Tuberculosis in Pregnancy
Condition:   Latent Tuberculosis Intervention:   Diagnostic Test: IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection Sponsors:   Queen Mary University of London;   University College, London;   City, University of London;   Imperial College London Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2019 Category: Research Source Type: clinical trials

Effect of Community Active Case Finding Strategies for Detection of Tuberculosis in Cambodia
Condition:   Tuberculosis Interventions:   Other: ACF with a seed-and-recruit model;   Other: ACF targeting household and neighborhood contacts;   Other: ACF targeting the older population using mobile screening units;   Other: Passive case finding Sponsors:   National University, Singapore;   KHANA Center for Population Health Research;   National Center for Tuberculosis and Leprosy Control;   Cambodian Anti-Tuberculosis Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2019 Category: Research Source Type: clinical trials

FujiLAM Prospective Evaluation Trial
Condition:   Diagnosis of Tuberculosis in People Living With HIV Intervention:   Device: Fujifilm SILVAMP TB LAM Sponsors:   Foundation for Innovative New Diagnostics, Switzerland;   Centre for Infectious Disease Research in Zambia;   Infectious Diseases Institute, Uganda;   Malawi-Liverpool-Wellcome Trust Clinical Research Programme;   Swiss TPH, Switzerland;   Ifakara Health Institute, Tanzania;   University of Cape Town;   Viet Tiep Hospital, Vietnam; &...
Source: ClinicalTrials.gov - September 13, 2019 Category: Research Source Type: clinical trials